Oxygen boost drug enters fight against deadly brain tumor
NCT ID NCT03862430
Summary
This study is testing if a new drug called NanO2 can help standard radiation and chemotherapy work better for people newly diagnosed with glioblastoma, a fast-growing brain tumor. The idea is that NanO2 delivers extra oxygen to the tumor, which may make radiation therapy more effective at killing cancer cells. About 87 participants will receive either NanO2 or a placebo (saltwater) infusion right before their radiation sessions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlantic Health System
Summit, New Jersey, 07901, United States
-
Center for Neurosciences
Tucson, Arizona, 85718, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
-
Ochsner Clinic Foundation
New Orleans, Louisiana, 70121, United States
-
Providence St. John's Cancer Institute
Santa Monica, California, 90404, United States
-
Saint Luke's Cancer Institute
Kansas City, Missouri, 64111, United States
-
St. Francis Medical Center, OSF Healthcare
Peoria, Illinois, 61637, United States
-
UC Irvine Health- Chao Family Comprehensive Cancer Center
Orange, California, 92868, United States
-
University Hospitals Seidman Cancer Center
Cleveland, Ohio, 44106, United States
-
University of Arizona
Tucson, Arizona, 85719, United States
-
Yale Cancer Center
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.